tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Compare Editas Medicine (EDIT) vs. Competitors

Compare
3,552 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$2.03
$198.17M
-0.85
63.71%
4 Buy
5 Hold
1 Sell
Moderate Buy
Cellectis SA
$4.07
$293.36M
-12.21
169.54%
2 Buy
2 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$6.02
$352.66M
-5.07
43.33%
9 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$8.25
$144.29M
-2.43
28.11%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$15.75
$345.09M
-0.04
-42.10%
6 Buy
1 Hold
0 Sell
Strong Buy
Caribou Biosciences
$1.46
$136.46M
-0.86
-5.19%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
2.03
0.82
67.77%
CLLS
Cellectis SA
4.07
2.56
169.54%
FHTX
Foghorn Therapeutics
6.02
1.61
36.51%
ELTX
Elicio Therapeutics
8.25
1.80
27.91%
VOR
Vor Biopharma
15.75
-11.45
-42.10%
CRBU
Caribou Biosciences
1.46
-0.06
-3.95%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts